DE69629367D1 - Verwendung eines antimykotikum - Google Patents

Verwendung eines antimykotikum

Info

Publication number
DE69629367D1
DE69629367D1 DE69629367T DE69629367T DE69629367D1 DE 69629367 D1 DE69629367 D1 DE 69629367D1 DE 69629367 T DE69629367 T DE 69629367T DE 69629367 T DE69629367 T DE 69629367T DE 69629367 D1 DE69629367 D1 DE 69629367D1
Authority
DE
Germany
Prior art keywords
pct
date nov
azole
sec
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629367T
Other languages
English (en)
Other versions
DE69629367T2 (de
Inventor
Gottfried Meingassner
Stewart Ryder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69629367D1 publication Critical patent/DE69629367D1/de
Application granted granted Critical
Publication of DE69629367T2 publication Critical patent/DE69629367T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
DE69629367T 1995-05-12 1996-05-10 Verwendung eines antimykotikum Expired - Lifetime DE69629367T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination
GB9509631 1995-05-12
PCT/EP1996/002022 WO1996035423A1 (en) 1995-05-12 1996-05-10 Antifungal composition

Publications (2)

Publication Number Publication Date
DE69629367D1 true DE69629367D1 (de) 2003-09-11
DE69629367T2 DE69629367T2 (de) 2004-06-09

Family

ID=10774361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629367T Expired - Lifetime DE69629367T2 (de) 1995-05-12 1996-05-10 Verwendung eines antimykotikum

Country Status (26)

Country Link
US (1) US5985906A (de)
EP (1) EP0824350B1 (de)
JP (1) JPH11504931A (de)
KR (1) KR100443535B1 (de)
CN (1) CN1100539C (de)
AT (1) ATE246504T1 (de)
AU (1) AU712914B2 (de)
CA (1) CA2219651C (de)
CY (1) CY2496B1 (de)
CZ (1) CZ291144B6 (de)
DE (1) DE69629367T2 (de)
DK (1) DK0824350T3 (de)
ES (1) ES2205042T3 (de)
FI (1) FI120079B (de)
GB (1) GB9509631D0 (de)
HK (1) HK1016064A1 (de)
HU (1) HU224920B1 (de)
IL (2) IL118219A (de)
MX (1) MX9708699A (de)
NO (1) NO317030B1 (de)
PL (1) PL322749A1 (de)
PT (1) PT824350E (de)
SK (1) SK150797A3 (de)
TW (1) TW464492B (de)
WO (1) WO1996035423A1 (de)
ZA (1) ZA963754B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
ES2219388T3 (es) * 1999-08-24 2004-12-01 Ariad Gene Therapeutics, Inc. 28-epi-rapalogos.
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
RU2396955C2 (ru) 2005-04-07 2010-08-20 Тояма Кемикал Ко., Лтд. Фармацевтическая комбинация и способ применения противогрибкового средства в комбинации
DK2070536T3 (da) 2006-10-06 2012-04-10 Toyama Chemical Co Ltd Farmaceutisk sammensætning med et phenylamidin-derivat og fremgangsmåde til anvendelse af den farmaceutiske sammensætning i kombination med et antifungalt middel
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
US8921642B2 (en) 2008-01-11 2014-12-30 Massachusetts Eye And Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ

Also Published As

Publication number Publication date
HK1016064A1 (en) 1999-10-29
US5985906A (en) 1999-11-16
TW464492B (en) 2001-11-21
ZA963754B (en) 1997-11-10
SK150797A3 (en) 1998-05-06
KR100443535B1 (ko) 2004-12-17
NO975134L (no) 1997-11-07
HUP9801140A3 (en) 2000-07-28
FI120079B (fi) 2009-06-30
KR19990014708A (ko) 1999-02-25
ATE246504T1 (de) 2003-08-15
CZ291144B6 (cs) 2002-12-11
CN1100539C (zh) 2003-02-05
IL118219A (en) 2001-08-26
CA2219651C (en) 2007-03-27
AU5818396A (en) 1996-11-29
CZ354797A3 (cs) 1998-02-18
PL322749A1 (en) 1998-02-16
EP0824350B1 (de) 2003-08-06
FI973812A (fi) 1997-11-11
IL118219A0 (en) 1996-09-12
AU712914B2 (en) 1999-11-18
EP0824350A1 (de) 1998-02-25
NO317030B1 (no) 2004-07-26
CA2219651A1 (en) 1996-11-14
WO1996035423A1 (en) 1996-11-14
MX9708699A (es) 1998-02-28
PT824350E (pt) 2003-12-31
JPH11504931A (ja) 1999-05-11
FI973812A0 (fi) 1997-09-26
NO975134D0 (no) 1997-11-07
DK0824350T3 (da) 2003-11-03
HU224920B1 (en) 2006-04-28
HUP9801140A2 (hu) 1999-01-28
CN1184427A (zh) 1998-06-10
CY2496B1 (en) 2005-09-02
GB9509631D0 (en) 1995-07-05
DE69629367T2 (de) 2004-06-09
ES2205042T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
DE69629367D1 (de) Verwendung eines antimykotikum
ATE204164T1 (de) Pflaster zur behandlung von nagelmykosen
CO4410196A1 (es) Antagonistas heterociclicos de receptores de taquicininas
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
MXPA03000686A (es) Acoplamiento eficiente de ullmann mediado por ligandos de anilinas y azoles.
NO20005264L (no) Heterocyklisk substituerte amider, deres fremstilling og anvendelse
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
NO973857L (no) 1-aryl-2-acylamino-etanforbindelser og deres anvnedelse som neurokinin-, spesielt neurokinin-1-antagonister
BR9606821A (pt) Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida
NO981019D0 (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
GB0015246D0 (en) Method for the treatment of urinary incontinence
WO2001004354A3 (en) Use of ras inhibitors of inhibiting muscle atrophy
PT1387837E (pt) Novos derivados de azole e de triazole, processo para a sua preparacao e sua aplicacao como medicamentos anti-fungicos
NO975413L (no) Koboltmetallagglomerater, samt fremgangsmåte for fremstilling og anvendelse derav
DK0566666T3 (da) Nye glucohydrolase-inhibitorer anvendelige som antidiabetiske, antivirale og antimetastatiske midler
NO975084L (no) Bakteriostatisk preparat og dets anvendelse i metallbearbeidingsfluider
PL323305A1 (en) Applications of allyl amines
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.
NO20022778D0 (no) Fremgangsmåte for fremstilling av 2-(2-brometyl)-naftalen
ATE198315T1 (de) Dimethyl-substituierte cyclohexandienderivate
DE69400908D1 (de) Verwendung von riluzol zum schutz gegen strahlenschäden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R082 Change of representative

Ref document number: 824350

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE